Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Plant-derived cannabinoids as anticancer agents.
O'Reilly EM, Cosgrave JM, Gallagher WM, Perry AS. O'Reilly EM, et al. Among authors: gallagher wm. Trends Cancer. 2022 May;8(5):350-357. doi: 10.1016/j.trecan.2022.01.017. Epub 2022 Mar 5. Trends Cancer. 2022. PMID: 35260379
Epigenetics of malignant melanoma.
Moran B, Silva R, Perry AS, Gallagher WM. Moran B, et al. Among authors: gallagher wm. Semin Cancer Biol. 2018 Aug;51:80-88. doi: 10.1016/j.semcancer.2017.10.006. Epub 2017 Oct 23. Semin Cancer Biol. 2018. PMID: 29074395 Review.
epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer.
O'Reilly E, Tuzova AV, Walsh AL, Russell NM, O'Brien O, Kelly S, Dhomhnallain ON, DeBarra L, Dale CM, Brugman R, Clarke G, Schmidt O, O'Meachair S, Patil D, Pellegrini KL, Fleshner N, Garcia J, Zhao F, Finn S, Mills R, Hanna MY, Hurst R, McEvoy E, Gallagher WM, Manecksha RP, Cooper CS, Brewer DS, Bapat B, Sanda MG, Clark J, Perry AS. O'Reilly E, et al. Among authors: gallagher wm. JCO Precis Oncol. 2019;2019:PO.18.00134. doi: 10.1200/PO.18.00134. Epub 2019 Jan 14. JCO Precis Oncol. 2019. PMID: 30801051 Free PMC article.
Evaluating liquid biopsies for methylomic profiling of prostate cancer.
Silva R, Moran B, Russell NM, Fahey C, Vlajnic T, Manecksha RP, Finn SP, Brennan DJ, Gallagher WM, Perry AS. Silva R, et al. Among authors: gallagher wm. Epigenetics. 2020 Jun-Jul;15(6-7):715-727. doi: 10.1080/15592294.2020.1712876. Epub 2020 Jan 31. Epigenetics. 2020. PMID: 32000564 Free PMC article.
Fibulins and cancer: friend or foe?
Gallagher WM, Currid CA, Whelan LC. Gallagher WM, et al. Trends Mol Med. 2005 Jul;11(7):336-40. doi: 10.1016/j.molmed.2005.06.001. Trends Mol Med. 2005. PMID: 15961345 Review.
Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment.
Byrne AT, O'Connor AE, Hall M, Murtagh J, O'Neill K, Curran KM, Mongrain K, Rousseau JA, Lecomte R, McGee S, Callanan JJ, O'Shea DF, Gallagher WM. Byrne AT, et al. Among authors: gallagher wm. Br J Cancer. 2009 Nov 3;101(9):1565-73. doi: 10.1038/sj.bjc.6605247. Epub 2009 Oct 13. Br J Cancer. 2009. PMID: 19826417 Free PMC article.
Characterisation and manipulation of docetaxel resistant prostate cancer cell lines.
O'Neill AJ, Prencipe M, Dowling C, Fan Y, Mulrane L, Gallagher WM, O'Connor D, O'Connor R, Devery A, Corcoran C, Rani S, O'Driscoll L, Fitzpatrick JM, Watson RW. O'Neill AJ, et al. Among authors: gallagher wm. Mol Cancer. 2011 Oct 7;10:126. doi: 10.1186/1476-4598-10-126. Mol Cancer. 2011. PMID: 21982118 Free PMC article.
248 results